Results 131 to 140 of about 65,332 (276)
ABSTRACT Amyloidosis, characterized by the deposition of abnormal protein fibrils in organs, is classified as systemic or localized. Amyloid light chain (AL)‐type localized amyloidosis is uncommon, particularly when confined to the gastrointestinal tract.
Shunsuke Kojimahara +7 more
wiley +1 more source
Subcutaneous unfractionated heparin, or low–molecular-weight heparin, is commonly used for venous thromboembolism prophylaxis in hospitalized patients at increased risk for developing thrombosis.
Alexander J. Johnston +2 more
doaj +1 more source
INDUCTION OF TOLERANCE BY ORAL ADMINISTRATION OF FACTOR VIII AND TREATMENT OF HEMOPHILA [PDF]
Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a Subject a therapeutically effective amount of the deficient anti gen, wherein the antigen is not present in a liposome.
Alpan, Oral +3 more
core +1 more source
Pulsed electric field (PEF) processing qualitatively reshapes the phytochemical profile of red beet extracts, resulting in enhanced endothelial bioefficacy. Compared with conventional extraction, PEF‐treated extracts more effectively restore nitric oxide signaling, suppress endothelial inflammation, and normalize vascular structure in high‐fat diet ...
Eunju Jang +8 more
wiley +1 more source
Objective This study aimed to investigate the mechanisms of immune dysregulation in a pediatric patient with monogenic lupus driven by IKZF1 haploinsufficiency. Methods Peripheral immune cells from a patient with IKZF1 haploinsufficiency, patients with lupus with no currently known genetic mutations, and healthy controls were analyzed using single‐cell
Qi Zheng +6 more
wiley +1 more source
PERBANDINGAN PEMBERIAN HEPARIN INTRAVENA DAN SUBKUTAN TERHADAP KADAR PPT DAN PTTK PADA PENCEGAHAN DEEP VEIN THROMBOSIS [PDF]
Background: Thrombosis in the United States is the leading cause of death. About 2 million people die every year either because of an artery or vein thrombosis.
Rizki, Djanuar, Soesilowati, Danu
core
The DAWNA‐FES trial is a prospective, single‐center, single‐arm phase II study evaluating dalpiciclib plus endocrine therapy in patients with HR+/HER2− advanced breast cancer who have progressed on prior CDK4/6 inhibitors and have at least one [18F]FES‐positive lesion.
Ru Yao +12 more
wiley +1 more source
Investigation of sensitivity for coagulation factor deficiency in APTT and PT : how to perform it? [PDF]
Devreese, Katrien +2 more
core +1 more source
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source
Hematological Changes Post-Hemo and Peritoneal Dialysis Among Renal Failure Patients in Sudan
The objective of the study was to assess the changes that occur in various hematological parameters that may occur in renal failure patients after hemo and peritoneal dialysis sessions.
Mohamed Ali Mohamed +4 more
doaj

